• (11/5/2009)
  NANOTECHNOLOGISTS CREATE ARTIFICIAL PORE - Interview with Peixuan Guo, Ph.D., Director of the NIH Nanomedicine Development Center at the University of Cincinnati, Endowed Chair, and Professor of Biomedical Engineering
• (10/22/2009)
  MITOCHONDRIAL GENE DEFECTS AND DISORDERS - Interview with Marni J. Falk, M.D., Assistant Professor of Pediatrics, Division of Human Genetics, The Children's Hospital of Philadelphia
• (10/8/2009)
  BIOMOLECULAR COMPUTATION - Interview with Erik Winfree, Ph.D., Associate Professor of Computer Science, Computation and Neural Systems, and Bioengineering, California Institute of Technology
• (10/1/2009)
  NOVEL NANOCATALYST FOR PHARMACEUTICAL MANUFACTURING - Inteview with Eugene Zubarev, Ph.D., Associate Professor, Department of Chemistry, Rice University
• (9/24/2009)
  MONITORING EARLY SIGNS OF OXIDATIVE STRESS IN CANCER - Interview with Kate Carroll, Ph.D., Assistant Professor of Chemistry, College of Literature, Science, and the Arts, and Research Assistant Professor, Life Sciences Institute, University of Michigan
• (9/17/2009)
  NANOGAP SENSOR FOR SPEEDING UP DNA DETECTION - Interview with Zhiqiang Gao, Ph.D., Group Leader, Biosensors and Biodevices Group, Institute of Bioengineering and Nanotechnology in Singapore
• (9/10/2009)
  GENETIC LINK FOUND BETWEEN REPTILE AND HUMAN HEART EVOLUTION - Interview with Benoit Bruneau, Ph.D., Associate Investigator, Gladstone Institute of Cardiovascular Disease, and Associate Professor of Pediatrics, University of California-San Francisco
• (9/3/2009)
  GENE TARGETING IN HUMAN EMBRYONIC STEM CELLS - Interview with Dirk Hockemeyer, Ph.D., Postdoctoral Researcher, Whitehead Institute for Biomedical Research, Cambridge, MA
• (8/27/2009)
  NEW CRITICAL INSIGHTS ON APOPTOSIS - Interview with Marion MacFarlane, Ph.D., Group Leader, Receptor-mediated Signaling and Cell Death Program, Toxicology Unit, Medical Research Council, University of Leicester, U.K.
• (8/20/2009)
  A POWERFUL, NEW TOOL FOR DNA RESEARCH - Interview with Scott Silverman, Ph.D., Associate Professor, Department of Chemistry, University of Illinois at Urbana-Champaign
• (8/13/2009)
  MOLECULE FOR REGULATING HEART SIZE DISCOVERED - Interview with Michael Tsang, Ph.D., Assistant Professor, Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine
• (8/6/2009)
  GENE EVOLUTION PROCESS DISCOVERED - Interview with Ian Wood, Ph.D., Senior Lecturer, Institute of Membrane and Systems Biology, Faculty of Biological Sciences, University of Leeds
• (7/30/2009)
  REFLECTIONS ON BIOTECH WITH NOBEL LAUREATE DR. PHILLIP SHARP - Interview with Phillip Sharp, Ph.D., Professor, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
• (7/23/2009)
  A SYSTEMS BIOLOGY VIEW OF CANCER - Interview with Reinhard Laubenbacher, Ph.D., Professor, Virginia Bioinformatics Institute, Professor, Department of Mathematics, Virginia Tech, and Adjunct Professor, Department of Cancer Biology, Wake Forest University
• (7/16/2009)
  DELIVERING CELLS INTRANASALLY TO THE BRAIN - Interview with William Frey, Co-Director, Alzheimer's Research Center, Regions Hospital, St. Paul, MN, and Professor, Oral Biology and Pharmaceutics, University of Minnesota
• (7/9/2009)
  NOVEL BIOMARKER FOR AGE-RELATED MACULAR DEGENERATION - Interview with Jayakrishna Ambati, M.D., Professor of Physiology and Professor and Vice Chair of Ophthalmology and Visual Sciences, University of Kentucky
• (7/2/2009)
  WHY JUNK DNA IS NOT TRASH - Inteview with Kevin Verstrepen, Ph.D., Group Leader, Laboratory of Systems Biology, Flanders Institute for Biotechnology, and Associate Professor, Biological Engineering, Catholic University of Leuven
• (6/25/2009)
  ALUMINUM OXIDE NANOPORE FOR DNA ANALYSIS - Interview with Bala Murali Venkatesan, Fourth-Year Graduate Student, Department of Electrical and Computer Engineering Department, University of Illinois at Urbana-Champaign
• (6/18/2009)
  THREE-D MODEL OF CRITICAL H1N1 PROTEIN - Interview with Sebastian Maurer-Stroh, Ph.D., Principal Investigator, Bioinformatics Institute, Biopolis, Singapore
• (6/11/2009)
  ANTIVIRAL RESPONSE LINKED TO KEY IMMUNE SYSTEM PROTEIN - Interview with Allan Zajac, Ph.D., Associate Professor, University of Alabama at Birmingham
• (6/4/2009)
  THE IMPACT OF DISEASE ON HUMAN EVOLUTION - Interview with Marleen Zuk, Ph.D., Professor of Biology at the University of California-Riverside
• (5/28/2009)
  EARLY ALZHEIMER'S DIAGNOSIS AND POTENTIAL THERAPIES - Interview with Hemant K. Paudel, Ph.D., Associate Professor, Department of Neurology and Neurosurgery, McGill University, and Project Director, Bloomfield Center for Research in Aging, Lady Davis Institute for Medical Research, The Sir Mortimer B. Davis-Jewish General Hospital
• (5/21/2009)
  NEW GENETIC CLUES TO BLOOD PRESSURE REGULATION - Interview with Daniel Levy, M.D., Director of the National Heart, Lung, and Blood Institute's Framingham Heart Study and Professor of Medicine at the Boston University School of Medicine
• (5/14/2009)
  CARBON DIOXIDE TRANSPORT PROTEIN IN MICROALGAE IDENTIFIED - Interview with Martin Spalding, Ph.D., Professor and Chair of the Department of Genetics, Development, and Cell Biology at Iowa State University
• (5/7/2009)
  CHINA'S CHANGING PHARMACEUTICAL LANDSCAPE - Interview with Michael Keech, Director, Pharmaceutical and Life Sciences Advisory Services Group, PricewaterhouseCoopers
• (4/30/2009)
  FACING BIOTECH'S CHALLENGES AND SEIZING OPPORTUNITIES IN 2009 - Interview with Joshua Boger, Ph.D., Founder and CEO, Vertex Pharmaceuticals, and Chairman, Board of Directors, Biotechnology Industry Organization (BIO), and James Greenwood, President and CEO, BIO
• (4/23/2009)
  LINKING LOW AEROBIC FITNESS AND FATTY LIVER DISEASE - Interview with John Thyfault, Ph.D., Assistant Professor and Health Scientist, Department of Internal Medicine, University of Missouri-Columbia
• (4/16/2009)
  BIOTECHNOLOGY IN GEORGIA - Interview with Charles Craig, President of Georgia Bio; Stephen Hill, President, Solvay Pharmaceuticals, Inc.; and Russell Medford, M.D., Ph.D., President and CEO, Atherogenics, Inc.
• (4/9/2009)
  HUMAN BODY LICE mtDNAs PROVIDE PIECES TO NEW GENOMIC PUZZLE - Interview with Stephen Barker, Ph.D., Associate Professor and Reader, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia
  sponsored by: MS in Quality Assurance and Regulatory Affairs from Northwestern University School of Continuing Studies
• (4/2/2009)
  THE EMERGING FIELD OF NUTRIGENOMICS - Inteview with Eugene Kolker, Ph.D., Chief Data Officer, Seattle Children's Hospital, Head, Bioinformatics & High-Throughput Analysis Laboratory, Seattle Children's Research Institute and Vural Ozdemir, M.D., Ph.D., Research Assistant Professor in Bioethics, Department of Social and Preventive Medicine, Faculty of Medicine, University of Montreal
• (3/26/2009)
  IMPROVING THE EFFECTIVENESS OF THE TB VACCINE - Interview with Robert Hunter Jr., M.D., Ph.D., Chair of the Department of Pathology and Laboratory Medicine at the University of Texas Medical School in Houston
• (3/19/2009)
  HOW TO MAKE BIOINDUSTRY ALLIANCES WORK MORE EFFICIENTLY AND EFFECTIVELY - Interview with Salima Lin, Global Strategy and Market Development Leader, IBM’s Life Science Industry
• (3/12/2009)
  miRNA BIOMARKERS FOR DRUG-INDUCED LIVER INJURY - Interview with David Galas, Ph.D., Senior Vice President of Strategic Partnerships, Institute for Systems Biology
  sponsored by: Exiqon Life Sciences
• (3/5/2009)
  HUMAN ANTIBODIES MAKE DARWINIAN LEAPS TO ATTACK MICROBIAL INFECTIONS - Interview with Ashok Bhagwat, Ph.D., Professor of Chemistry, Department of Chemistry, Wayne State University
• (2/26/2009)
  RESEARCH CASTS DOUBT ON FREE RADICAL ROLE IN AGING - Interview with Siegfried Hekimi, Ph.D., Strathcona Chair of Zoology and Robert Archibald & Catherine Louise Campbell Chair in Developmental Biology, McGill University
• (2/19/2009)
  CORPORATE ROUNDTABLE ON HUMAN DNA VACCINES - with panelists Avtar Dhillon, M.D., Joseph Kim, Ph.D., Michael Egan, Ph.D., Jeffrey Ulmer, Ph.D., Alan King, Ph.D., and Robert Bernard
• (2/12/2009)
  CHARLES DARWIN AND THE TRANSFORMATION OF SCIENCE - Interview with Francisco Ayala, Ph.D., University Professor and Donald Bren Professor of Biological Sciences, Ecology & Evolutionary Biology, School of Biological Sciences, University of California-Irvine
• (2/5/2009)
  STEM CELL THERAPIES ON THE RISE - Linda Powers, Cofounder and Managing Director of Toucan Capital, is interviewed by GEN's Editor in Chief, John Sterling
• (1/29/2009)
  HOW HUMAN GENES ARE ILL-EQUIPPED FOR THE MODERN WORLD - Interview with Gregory Gibson, Ph.D., Professor of Genetics, The School of Biological Sciences, The University of Queensland, Brisbane, Australia
• (1/22/2009)
  NEW WAY OF LOOKING AT PEDIATRIC INFECTIOUS DISEASES - Interview with Jean-Laurent Casanova, M.D., Ph.D., Professor of Medicine, Head of the Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University and Editor in Chief of a new peer-reviewed journal, Inborn Errors of Immunity
• (1/15/2009)
  NOVEL GLIOBLASTOMA MOUSE MODEL - Interview with Inder Verma, Ph.D., Professor, Laboratory of Genetics, Salk Institute for Biological Studies
  sponsored by: MS in Quality Assurance and Regulatory Affairs from Northwestern University School of Continuing Studies
• (1/8/2009)
  NOVEL METHOD FOR DETECTING REACTIVE OXYGEN SPECIES - Inteview with Niren Murthy, Ph.D., Principal Investigator, Laboratory for Biomaterials and Molecular Imaging, and Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University
• (12/31/2008)
  EVO DEVO AND ENDLESS FORMS MOST BEAUTIFUL - Interview with Sean Carroll, Ph.D., Professor of Molecular Biology and Genetics and an Investigator with the Howard Hughes Medical Institute at the University of Wisconsin
• (12/24/2008)
  X FILES OF BIOLOGY - LARGE-SCALE GENE SILENCING MYSTERY SOLVED - Interview with Craig Pikaard, Ph.D., Professor of Biology, Washington University in St. Louis
• (12/18/2008)
  ENZYME DISCOVERY MAY LEAD TO IMPROVED HEART AND STROKE THERAPIES - Interview with Peter Davies, Ph.D., Professor of Biochemistry and Biology, and Canada Research Chair in Protein, Engineering, Queen's University, Kingston, Ontarion, Canada
• (12/11/2008)
  NOVEL CANCER THERAPY MAY ARISE FROM DWARF POPULATION STUDY - Interview with Valter D. Longo, Ph.D., Associate Professor, Gerontology and Alzheimer's Research, Biological Sciences, College of Letters Arts & Sciences, Leonard Davis School of Gerontology, University of Southern California
• (12/4/2008)
  ARTIFICIAL CELLS FOR MEDICAL IMPLANTS - Interview with David LaVan, Ph.D., Project Leader, Functional Properties Group, Materials Science and Engineering Laboratory, U.S. National Institute of Standards and Technology
• (11/26/2008)
  CANCER-KILLING COMPOUND DEVELOPED FROM SALAD PLANT - Interview with Tomikazu Sasaki Ph.D., Associate Professor of Chemistry, University of Washington, and Co-Founder of Artemisia Biomedical, Inc.
• (11/20/2008)
  ANTIBODY FIGHTS FAT - Interview with Kim Janda, Ph.D., Ely R. Callaway, Jr. Professor of Chemistry, Member of The Skaggs Institute for Chemical Biology, and Director of the Worm Institute of Research and Medicine, Scripps Research Institute
• (11/13/2008)
  DISCOVERING DRUGS AND BIOFUELS IN TROPICAL SEAS - Margo Haygood, Ph.D., Professor of Marine and Biomolecular Systems, Environmental and Biomolecular Systems Division, Department of Science and Engineering, Oregon Health & Science University
• (11/6/2008)
  MICROSIZING GENETICS TESTING - Interview with James Landers, Ph.D., Professor of Chemistry, Professor of Mechanical Engineering, and Associate Professor of Pathology, University of Virginia
• (10/30/2008)
  GENE THERAPY RESTORES VISION TO BLIND MICE - Interview with Richard Masland, PhD, Director, Cellular Neurobiology Laboratory, Department of Neurosurgery, Massachusetts General Hospital
• (10/23/2008)
  PROMISING NEW TREATMENT FOR ALCOHOLISM - Interview with Selena Bartlett, Ph.D., Director, Preclinical Development Group, Gallo Research Center, University of California-San Francisco
• (10/15/2008)
  CLEAR GENETIC LINK BETWEEN IMMUNE AND NERVOUS SYSTEMS ESTABLISHED - Interview with Alejandro Aballay, Ph.D., Assistant Professor, Department of Molecular Genetics and Microbiology, Duke University Medical School
• (10/9/2008)
  NANOPARTICLE TROJAN HORSE MOLECULAR DELIVERY SYSTEM - Interview with Dr. Ian Larson, Senior Lecturer in Pharmaceutics and Formulation Science, Monash University
• (10/2/2008)
  PROMISING ADVANCE IN THE BATTLE AGAINST BIRD FLU AND INFLUENZA EPIDEMICS - Interview with Robert Krug, Ph.D., Professor and Chairman of Molecular Genetics & Microbiology at the University of Texas at Austin
• (9/25/2008)
  ROUNDTABLE DISCUSSION ON BIOTECH/PHARMA DEALS - Martina Molsbergen, VP, Business Development, Crucell; Barbara Yanni, Chief Licensing Officer, Merck & Co.; David Colpman, Senior VP, Business Development, Shire Pharmaceuticals; and Joern-Peter Halle, Head, Early-Stage Licensing, Merck Serono, a division of Merck KGaA
• (9/18/2008)
  MAKING NEW YORK CITY A BIO-MECCA - Lenzie Harcum, Vice President of Business Development in Biosciences at the New York City Economic Development Corporation, and Bill Fair, Managing Director at Alexandria Real Estate Equities
• (9/11/2008)
  SINGLE miRNA MOLECULE CONTROLS BLOOD VESSEL DEVELOPMENT - Interview with Jason Fish, Ph.D., Postdoctoral Fellow in the Laboratory of Deepak Srivastava at the Gladstone Institute of Cardiovascular Disease
• (9/4/2008)
  IMPROVING CANCER THERAPY BY FINDING THE ORIGINAL NORMAL CELL - Interview with Robert Wechsler-Reya, Ph.D., Associate Professor of Pharmacology and Cancer Biology, Duke University Medical Center
• (8/28/2008)
  MICROORGANISMS ATTACK THE WORLD'S ENERGY CRISIS - Interview with Bruce Rittmann, Ph.D., Director of the Center for Environmental Biotechnology, Biodesign Institute, Arizona State University
• (8/20/2008)
  FIRST TISSUE CULTURE SYSTEM FOR MODELING HCV INFECTION - Interview with Martina Buck, Ph.D., Assistant Professor of Medicine and Researcher at UC San Diego's Department of Medicine and Moores UCSD Cancer Center
• (8/14/2008)
  MAGNETIC NANOPARTICLES COMBAT CANCER - Interview with John McDonald, Ph.D., Professor and Chair of the School of Biology at Georgia Tech and Chief Research Scientist at the Ovarian Cancer Institute
• (8/7/2008)
  CLINICAL TRIAL ETHICS IN THE DEVELOPING WORLD - Jonathan Kimmelman, Ph.D., Assistant Professor in the Biomedical Ethics Unit/Social Studies of Medicine Department, McGill University
• (8/6/2008)
  GEN ROUNDTABLE DISCUSSION ON CURRENT TRENDS IN HIGH THROUGHPUT SCREENING
• (7/31/2008)
  ANTIBIOTICS ENHANCE RNAI CAPABILITIES - Interview with Peng Jin, Ph.D., Assistant Professor, Department of Human Genetics, Emory University School of Medicine
• (7/24/2008)
  NEW MODEL FOR CREATING A DRUG DISCOVERY COMPANY - Interview with Ben Conway, Founder and Managing Director, Boston-based Johnston Blakely and Co., and Isaac Ro, Senior Analyst, Boston-based Leerink Swann
• (7/17/2008)
  REVOLUTIONIZING THE PHARMA INDUSTRY VIA VIRTUAL R&D - Neil Patel, PharmD., Director of Pharmaceutical R&D Operations, PricewaterhouseCoopers
• (7/10/2008)
  NOVEL INSIGHTS INTO CANCER AND THE PROCESS OF AGING - Interview with Jill Fuss, Ph.D., Research Scientist at Lawrence Berkeley National Laboratory
• (7/3/2008)
  NEW INITIATIVE FOR MAPPING ALL CELL TYPES DERIVED FROM HUMAN EMBRYONIC STEM CELLS --- Interview with Michael West, Ph.D., Chief Executive Officer, BioTime, Inc.
• (6/26/2008)
  NOVEL METHOD FOR REMYELINATING NERVE CELLS - Interview with Steve Goldman, M.D., Ph.D., Professor of Neurology and Chief of the Division of Cell and Gene Therapy at the University of Rochester Medical Center
• (6/19/2008)
  IMPLICATIONS OF GINA FOR THE BIOTECH AND PHARMA INDUSTRIES --- Interview with Sharon Terry, President and CEO of the Genetic Alliance
• (6/12/2008)
  NOVEL IMMUNE SYSTEM MONITORING TOOL --- Interview with Owen Witte, M.D., Researcher, UCLA Jonsson Cancer Center, and a Howard Hughes Medical Institute Investigator
• (6/5/2008)
  NOVEL COMPOUND MIGHT LEAD TO NEW THERAPY FOR HIGH BLOOD PRESSURE --- Interview with Dr. David Ostrov, from the University of Florida College of Medicine.
• (5/29/2008)
  EVIDENCE-BASED MEDICINE (EBM) --- Interview with Dan Leonard, President of the National Pharmaceutical Council
• (5/22/2008)
  NOVEL APPROACH TO CANCER DRUG DEVELOPMENT --- Interview with Ronen Marmorstein, Ph.D., Professor, Gene Expression and Regulation Program, Wistar Institute
  sponsored by: BIO-RAD
• (5/15/2008)
  GENE THERAPY FOR FATAL NEURODEGENERATIVE DISEASE IN CHILDREN - Interview with Ronald G. Crystal, M.D., Professor and Chairman of the Department of Genetic Medicine of the Weill Medical College of Cornell University
• (5/8/2008)
  INTERACTING WITH THE FDA-ISSUES AND STRATEGIES --- Interview with Bruce Mackler, Ph.D., J.D., senior advisor on FDA matters and due diligence concerns to financial groups and investment companies
• (5/1/2008)
  TRENDS IN THE GLOBALIZATION OF BIOTECHNOLOGY - Exclusive GEN Panel Discussion with Four Co-Chairs of the Upcoming Biotechnology Industry Organization's (BIO) Annual International Convention
• (4/24/2008)
  NEW PATH FOR TREATING AND PREVENTING EYE DISEASE --- Interview with Dean Li, M.D.,Ph.D., Professor of Internal Medicine, University of Utah School of Medicine, and Research Scientist with the University's Program in Human Molecular Biology and Genetics
• (4/17/2008)
  miRNAs AND CANCER - Interview with George Calin, M.D., Ph.D., Associate Professor, Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center
  sponsored by: EXIQON
• (4/10/2008)
  ADVANCES IN DRUG DELIVERY AND TISSUE ENGINEERING - Interview with Robert Langer, Ph.D., Institute Professor, Chemical and Biomedical Engineering, MIT
• (4/3/2008)
  BREATH TEST FOR DISEASE DIAGNOSIS - Interview with Masood Yousef, Ph.D., senior research assistant in the Welsh Centre for Printing and Coating, Swansea University School of Engineering
• (3/27/2008)
  LINKING CHANGES IN GENE NETWORKS TO DISEASE - Interview with Eric Schadt, Ph.D., Executive Scientific Director of Research Genetics for Rosetta Inpharmatics, Inc., a wholly-owned subsidiary of Merck & Co.
• (3/20/2008)
  TRANSFORMING ORTHOPEDIC SURGERY WITH MOLECULAR MEDICINE - Interview with Thomas Einhorn, M.D., Chairman of the Department of Orthopedic Surgery and Professor of Orthopedic Surgery, Biochemistry, and Biomedical Engineering at Boston University
• (3/13/2008)
  DISCOVERY OF A CHEMICAL SIGNATURE IN THE BRAIN FOR MANIC DEPRESSION - Interview with Tsz Tsang, Ph.D., Department of Biomolecular Medicine, Imperial College London
• (3/6/2008)
  DEFINING CANCER'S GENETIC SUPPORT NETWORK - Interview with Sayan Mukherjee, Ph.D. and Elena Edelman from the Institute for Genome Sciences and Policy at Duke University
• (2/28/2008)
  VENTURE CAPITAL TRENDS FOR 2008 - Interview with Brian Hughes and Packy Kelly, co-leaders of KPMG’s venture capital practice.
• (2/21/2008)
  IDENTIFICATION OF A HEART ATTACK RESPONSE AND CARDIAC DAMAGE GENE - Interview with Richard Bucala, M.D., Ph.D., Professor of Medicine, Pathology, Epidemiology, and Public Health, Yale University School of Medicine
• (2/14/2008)
  NEW CELLULAR RECEPTOR FOR HIV - Interview with Anthony Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, and Chief of NIAID’s Laboratory of Immunoregulation.
• (2/7/2008)
  CHEMICAL BUFFER BREAKTHROUGH - Interview with Yi Lu, Ph.D., Professor of Chemistry, and Nathan Sieracki, Graduate Student, University of Illinois at Urbana-Champaign
• (1/31/2008)
  FRUIT FLY DISCOVERY MAY HELP IN CANCER PREVENTION - Interview with Dirk Bohmann, Ph.D., Professor of Genetics, Department of Biomedical Genetics, University of Rochester Medical Center
• (1/24/2008)
  RESEARCHERS CREATE BEATING HEART IN THE LABORATORY - Interview with Doris Taylor, Ph.D., Director of the University of Minnesota Center for Cardiovascular Repair and Medtronic Bakken Professor of Medicine and Physiology
• (1/18/2008)
  KEY IMMUNE RESPONSE REGULATORY GENES IDENTIFIED - Interview with Xiaojing Ma, Ph.D., Professor of Microbiology and Immunology in Pediatrics, Professor of Microbiology and Immunology, and Associate Director, Host Defenses Curriculum, Weill Cornell Medical College
• (1/10/2008)
  NEW MODEL FOR PREDICTING THE MOLECULAR RESPONSE OF LIVING CELLS TO GENETIC OR ENVIRONMENTAL CHANGE - Interview with Nitin Baliga, Ph.D., Associate Professor. Institute for Systems Biology
• (1/3/2008)
  IS THERE MORE FUNCTIONAL DNA IN THE GENOME THAN WE THOUGHT - Interview with Andrew McCallion, Ph.D., Assistant Professor, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine
• (12/27/2007)
  BIOGEN IDEC'S NOVEL INNOVATION INCUBATOR FACILITY - Interview with Rainer Fuchs, Ph.D., Vice President and Executive Director of the Biogen Idec Innovation Incubator (bi3)
• (12/20/2007)
  A NEW KIND OF DNA MODIFICATION IN BACTERIA - Interview with Peter Dedon, M.D., Ph.D., Professor of Toxicology and Biological Engineering, Associate Head-Department of Biological Engineering, Deputy Director-Center for Environmental, Health Sciences at the Massachusetts Institute of Technology
• (12/13/2007)
  CAN SCIENCE REALLY SLOW DOWN THE HUMAN AGING PROCESS? - Interview with Michael Rose, Ph.D., Professor in Biological Sciences, University of California-Irvine, and Director of the Network for Experimental Research on Evolution, a University of California Multicampus Research Program
• (12/6/2007)
  NOVEL APPROACH TO COMBATING HIV INFECTION - Interview with Keith Garrison, Ph.D., post-doctoral fellow in UCSF's Division of Experimental Medicine
• (11/29/2007)
  MEMBRANE SANDWICH ELECTROPORATION FOR GENE DELIVERY - interview with L. James Lee, Ph.D., Helen C. Kurtz Professor in the Department of Chemical and Biomolecular Engineering at Ohio State University
  sponsored by: Bio-Rad
• (11/21/2007)
  NEW MODEL FOR INVESTIGATING PROTEIN FOLDING, PACKAGING, AND EXPORT FROM CELLS - Interview with William Balch, Ph.D., and Evan Powers, Ph.D., from The Scripps Research Institute.
• (11/15/2007)
  JUMPING GENES FOR SAFER GENE DELIVERY - interview with Margy S. Lambert, Ph.D., Associate Biosafety Officer, Office of Biological Safety, Environment, Health and Safety Department, University of Wisconsin-Madison.
  sponsored by: Bio-Rad
• (11/8/2007)
  MAGNETICALLY DRIVEN NANOPARTICLE GENE DELIVERY - Interview with Robert J. Levy, M.D., William J. Rashkind Chair of Pediatric Cardiology, The Children's Hospital of Philadelphia
  sponsored by: Bio-Rad
• (11/1/2007)
  RESTORING HEARING LOSS IN HUMANS THRU GENE DELIVERY - Interview with Dr. Jeffrey Holt, associate professor in the Department of Neuroscience at the University of Virginia.
  sponsored by: Bio-Rad
• (10/25/2007)
  DRUG-DEVICE COMBINATION PRODUCTS - Veronika Litinski, Director, MaRS Venture Group, is interviewed by John Sterling, Editor-in-Chief, Genetic Engineering and Biotechnology News, on drug-device combination products.
• (10/18/2007)
  BIOTECHNOLOGY IN CHINA -- BEWARE! - GEN's Editor-in-Chief John Sterling interviews Dr. Peter Navarro from the Paul Merage School of Business at the University of California, Irvine, about the pitfalls of doing biotech R&D and manufacturing in China.
• (10/11/2007)
  REVOLUTIONARY INSIGHT ON GENETIC VARIATION AMONG PEOPLE - GEN's Editor-in-Chief John Sterling talks to Michael Snyder, Ph.D., Cullman Professor of Molecular, Cellular and Developmental Biology, at Yale University.
• (10/4/2007)
  NOVEL STRATEGY FOR TREATMENT OF HIV AND OTHER VIRAL INFECTIONS - GEN's Editor-in-Chief John Sterling interviews Stephen Becker, M.D., Chief Medical Officer, Koronis Pharmaceuticals
• (9/27/2007)
  UNIVERSITY-BASED CONTRACT MANUFACTURING ORGANIZATIONS: HOW TO SUCCEED IN A VERY COMPETITIVE MARKET - GEN's Editor-in-Chief John Sterling interviews Michael Meagher, Ph.D., Donald F. and Mildred T. Othmer Distinguished Professor of Chemical and Biomolecular Engineering, and Director, University of Nebraska-Lincoln Biological Process Development Facility
• (9/20/2007)
  NEW MECHANISM TO EXPLAIN MEMORY LOSS IN ALZHEIMER'S - GEN's Editor-in-Chief John Sterling interviews Dr. Lennart Mucke from the Gladstone Institute of Neurological Disease.
• (9/13/2007)
  RISK-REDUCED BIOTECH BUSINESS MODELS - GEN's Editor-in-Chief John Sterling interviews Bob More, Domain Associates, Ted Schroeder, Cadence Pharmaceuticals, and Steve Kelly, Innovive Pharmaceuticals
• (9/6/2007)
  NANOPARTICLE-BASED DRUG DELIVERY AND THERAPY - GEN's Editor-in-Chief John Sterling interviews Alan Crane, CEO, Tempo Pharmaceuticals
• (8/30/2007)
  TAKING THE RISK OUT OF CLINICAL DEVELOPMENT - GEN's Editor-in-Chief John Sterling interviews Kenneth Carter, Ph.D., President and CEO, Avalon Pharmaceuticals
• (8/23/2007)
  TURNING MICE INTO HUMAN LIVER CELL FACTORIES - GEN's Editor-in-Chief John Sterling talks to Markus Grompe, M.D., professor of molecular and medical genetics, and pediatrics, Oregon Health and Science University School of Medicine
• (8/16/2007)
  KEY LEGAL AND REGULATORY ISSUES FACING THE GLOBAL BIOTECHNOLOGY INDUSTRY - GEN's Editor-in-Chief John Sterling interviews Robert Bohrer, J.D., LL.M, Professor of Law at California Western School of Law and Executive Editor of Biotechnology Law Report (Mary Ann Liebert, Inc., Publishers), on key biotechnology legal and regulatory issues.
• (8/9/2007)
  THE FDA'S TASK FORCE REPORT ON NANOTECHNOLOGY - GEN's Editor-in-Chief John Sterling interviews Richard Canady, Ph.D., DABT, Senior Health Scientist, U.S. Food and Drug Administration, about the FDA’s Task Force Report on Nanotechnology
• (8/2/2007)
  INDIVIDUALIZED CANCER THERAPY - GEN's Editor-in-Chief, John Sterling, interviews Dr. Robert Nagourney, Medical and Laboratory Director at Rational Therapeutics, about individualizing cancer therapies for patients.
• (7/26/2007)
  NEXT GENERATION OF DNA AND RNA MICROARRAYS - John Sterling, Editor-in-Chief of GEN, interviews Claude Gagne, Ph.D., Associate Professor of Life Sciences, New York Institute of Technology School of Health Professions, Behavioral, and Life Sciences
• (7/19/2007)
  THE USE OF ANIMAL MODELS IN BIOLOGICAL RESEARCH - GEN’s Editor-in-Chief, John Sterling, interviews Cheryl Marks, Ph.D., associate director of the division of cancer biology at the National Cancer Institute and program director of the Mouse Models of Human Cancers Consortium.
• (7/12/2007)
  DERIVING BIOIDENTICAL HUMAN STEM CELLS FROM UNFERTILIZED EGGS - GEN’s Editor-in-Chief John Sterling inteviews Jeffrey Janus, President, and Jeff Krstich, CEO, of International Stem Cell Corporation.
• (7/3/2007)
  NON-VOLTAGE-GATED ION CHANNELS AS CNS DRUG TARGETS - GEN's Editor-in-Chief John Sterling interviews Michael Cascio, Ph.D., Assistant Professor, Department of Molecular Genetics and Biochemistry, University of Pittsburgh
• (6/28/2007)
  REAL TIME QUANTITATIVE PCR - RT-qPCR - IN A CLINICAL REFERENCE LABORATORY - GEN's Editor-in-Chief, John Sterling, interviews Jeffery Stevenson, Ph.D., ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories
  sponsored by: BIO-RAD
• (6/21/2007)
  CANCER DRUG TARGET IDENTIFICATION AND VALIDATION - GEN's Editor-in-Chief John Sterling interviews Sukru Tuzmen , Ph.D., Investigator, Head of Molecular Genetics Laboratory , Pharmaceutical Genomics Division, Translational Genomics Research Institute (TGEN)
  sponsored by: BIO-RAD
• (6/14/2007)
  microRNAs AND CANCER SUSCEPTIBILITY - GEN's Editor-in-Chief John Sterling interviews Linda Siracusa, Ph.D., Associate Professor of Microbiology and Immunology at Jefferson Medical College of Thomas Jefferson University
  sponsored by: BIO-RAD
• (6/7/2007)
  DIRECTED EVOLUTION OF NON-BIOLOGICAL PROTEINS - GEN's Editor-in-Chief interviews John C. Chaput, Ph.D., Principal Investigator, Center for Bio-Optical Nanotechnology, Biodesign Institute, Arizona State University.
  sponsored by: BIO-RAD
• (5/31/2007)
  PREPARING FOR PANDEMIC FLU - GEN's Editor-in-Chief John Sterling interviews Dr. David Ozonoff from the Boston University School of Public Health
• (5/24/2007)
  TRANSLATING PROTEOMICS AND BIOMARKER RESEARCH FINDINGS INTO THE CANCER CLINIC - GEN's Editor-in-Chief John Sterling interviews Dr. Amanda Paulovich from the Fred Hutchinson Cancer Research Center.
• (5/17/2007)
  MIRACLE MEDICINES: SEVEN LIFESAVING DRUGS AND THE PEOPLE WHO CREATED THEM - GEN's Editor-in-Chief John Sterling interviews best selling author Robert Shook.
• (5/10/2007)
  GLOBAL BIOINDUSTRY TRENDS IN 2007 - GEN's Editor-in-Chief John Sterling interviews Glen Giovannetti, Global Biotechnology Leader, Ernst & Young
• (5/3/2007)
  HOW SCIENTISTS CAN MAKE A SUCCESSFUL TRANSITION FROM THE ACADEMIC WORLD TO A CAREER IN THE BIOPHARMACEUTICAL BUSINESS - GEN's Editor-in-Chief John Sterling inteviews Dr. Gail Naughton, the Dean of the College of Business Administration at San Diego State University.
• (4/19/2007)
  ADVANCED DRUG DELIVERY STRATEGIES - GEN's Editor-in-Chief John Sterling interviews Felix Theeuwes, D.Sc., Chairman, Co-founder, and Chief Scientific Officer at DURECT Corporation.
• (4/12/2007)
  HUMAN EMBRYONIC STEM CELL RESEARCH: GEN's Editor-in-Chief John Sterling interviews William Caldwell, CEO of Advanced Cell Technology.
• (4/5/2007)
  DARWINIAN MEDICINE - GEN's Editor-in-Chief John Sterling interviews Sharon Moalem, Ph.D., from the Mount Sinai School of Medicine in New York.
• (3/29/2007)
  TEN YEARS AFTER DOLLY: WHERE ARE WE? - GEN's Editor-in-Chief Interviews Ian Wilmut, Ph.D., Director, Scottish Centre for Regenerative Medicine, University of Edinburgh, and Editor-in-Chief of Cloning & Stem Cells.
• (3/22/2007)
  RNAi TECHNOLOGY - GEN's Editor-in-Chief John Sterling interviews Richard Jorgensen, Ph.D., from the University of Arizona
  sponsored by: Sigma-Aldrich
• (3/15/2007)
  ZEBRAFISH AS MODEL ORGANISMS - GEN's Editor-in-Chief interviews Brant Weinstein, Ph.D., of the NIH, and associate editor of Zebrafish - a peer-review journal published by Mary Ann Liebert, Inc
• (3/8/2007)
  MINING THE HUMAN METABOLOME - GEN's Editor-in-Chief John Sterling talks with David Wishart, Ph.D., from the University of Alberta
• (3/1/2007)
  IMPROVING PHARMACEUTICAL PRODUCTIVITY - GEN's Editor-in-Chief John Sterling talks with Charles T. Gombar, Ph.D. from Wyeth Research.
• (2/22/2007)
  qPCR AND LATE-PCR, AN ADVANCED TECHNIQUE FOR DNA AMPLIFICATION - GEN's Editor-in-Chief John Sterling interviews Lawrence Wangh, Ph.D., from Brandeis University
  sponsored by: Eppendorf
• (2/15/2007)
  THE INVENTOR OF PCR - GEN's Editor-in-Chief John Sterling interviews the Nobel Prize winning inventor of PCR, Dr. Kary Mullis.
  sponsored by: Eppendorf
• (2/8/2007)
  qPCR APPLICATIONS IN SYSTEMS BIOLOGY AND GENE EXPRESSION RESEARCH: GEN's Editor-in-Chief John Sterling talks with John Quackenbush, Ph.D., from the Dana-Farber Cancer Institute.
  sponsored by: Eppendorf
• (2/1/2007)
  PROBE-BASED, REAL-TIME QUANTITATIVE PCR ASSAY DESIGN AND APPLICATIONS - GEN's Editor-in-Chief John Sterling interviews Gregory L. Shipley, Ph.D., Director, Quantitative Genomics Core Laboratory, The University of Texas Health Science Center-Houston.
  sponsored by: Eppendorf
• (1/25/2007)
  MUSLIM WOMEN IN SCIENCE - GEN's Editor-in-Chief John Sterling talks with Jo Handelsman, Ph.D., from the University of Wisconsin-Madison.
• (1/18/2007)
  ASSESSING THE POTENTIAL RISKS OF NANOTECHNOLOGY - GEN's Editor-in-Chief John Sterling talks with Dr Andrew Maynard, Chief Science Advisor to the Project on Emerging Nanotechnologies.
• (1/11/2007)
  RACE-BASED MEDICINE: REALITY OR AN ILLUSION? - GEN's Editor-in-Chief John Sterling talks with Dr. Joseph Graves Jr. from North Carolina A&T State University.
• (1/4/2007)
  SYNTHETIC BIOLOGY: PROMISES AND RISKS - GEN's Editor-in-Chief John Sterling talks with Raymond Zilinskas, Ph.D., from the Monterey Institute of International Studies
• (12/28/2006)
  2D ELECTROPHORESIS OF NUCLEIC ACIDS FOR BIOMARKER DISCOVERY, QUALITY CONTROL, AND VALIDATION - GEN's Editor-in-Chief John Sterling talks with Jon J. Jonsson, M.D., Ph.D., from the University of Iceland.
• (12/14/2006)
  ACHIEVING SUCCESS IN ONCOLOGY DRUG DISCOVERY AND DEVELOPMENT --GEN's Editor-in-Chief John Sterling talks with Michael Morrissey, PhD from Exelixis.
• (12/7/2006)
  GOVERNMENT CONTROL OF SCIENCE--THE SLIPPERY SLOPE, PART II. Price Controls of Drugs and the Potential Impact on the Biotechand Pharma Industry - GEN's Editor-in-Chief John Sterling talks with Dr. Elizabeth Whelan , President of the American Council on Science and Health about this controversial topic.
• (11/30/2006)
  Collaborations between Academia and Industry: A Conflict of Interest? Are they at Risk? - John Sterling's guest is Dr. Thomas Stossel of Brigham and Women’s Hospital in Boston.
• (11/22/2006)
  Dr. Richard Young from MIT talks with GEN's Editor-in-Chief John Sterling about transcriptional regulatory circuitry.
  sponsored by: Agilent Technologies
• (11/16/2006)
  Dr. Diane Esposito from the Cold Spring Harbor Laboratory talks with GEN's Editor-in-Chief John Sterling about microarrays in cancer research.
  sponsored by: Agilent Technologies
• (11/9/2006)
  Dr. Ryan Gill from the University of Colorado talks with GEN's Editor-in-Chief John Sterling about New Tools and Applications for Directed Genome Evolution.
  sponsored by: Agilent Technologies
• (11/2/2006)
  Seth Crosby, M.D., from the Washington University School of Medicine talks with GEN's Editor-in-Chief John Sterling about Microarray Technology and future trends in Microarray research.
  sponsored by: Agilent Technologies
• (10/26/2006)
  Dennis O'Rourke, PhD, talks with GEN's Editor-in-Chief John Sterling about Anthropological Genetics: Its impact on human population studies and its potential influence on drug development.
• (10/19/2006)
  Dr. Donny Strosberg, Professor of Infectology at Scripps-Florida, talks with GEN's Editor-in-Chief John Sterling about protein-protein interactions.
• (10/12/2006)
  David Weiner, Ph.D., from the University of Pennsylvania School of Medicine and Editor of DNA and Cell Biology - a peer-review journal published by Mary Ann Liebert, Inc. - talks with GEN's Editor-in-Chief John Sterling about DNA vaccines.
• (10/5/2006)
  Dr. David Bearss, from SuperGen, talks with GEN's Editor-in-Chief John Sterling about tackling bottlenecks in small-molecule drug discovery research.
• (9/28/2006)
  Dr. John Rossi, from the Beckman Research Institute of City of Hope and coeditor of the Mary Ann Liebert journal, Oligonucleotides, talks with GEN's Editor-in-Chief John Sterling about Oligonucleotides.
• (9/21/2006)
  Frank Yetter, from BusinessWire, talks with GEN's Editor-in-Chief John Sterling about 21st Century Communications Issues for Life Science Companies.
• (9/14/2006)
  Keith March, M.D., Ph.D. - Professor of Medicine in Indiana University’s Department of Medicine and Director of the Indiana Center for Vascular Biology and Medicine talks with GEN's editor-in-Chief John Sterling about Adult Stem Cells.
• (9/7/2006)
  James O. Hill, Ph.D. - Professor of Pediatrics and Medicine at the University of Colorado at Denver and Health Sciences Center in Denver, Colorado and Editor-in-Chief of Obesity Management - talks with GEN's editor-in-Chief John Sterling about the problem of obesity and how to treat it.
• (8/31/2006)
  Anna Barker, Ph.D. from the National Cancer Institute talks with GEN's Editor-in-Chief John Sterling about novel approaches to detecting and treating cancer.
• (8/24/2006)
  Caroline Kovac, Ph.D. from IBM Healthcare and Life Sciences talks with GEN's Editor-in-Chief John Sterling about the revolution in information-based medicine.
• (8/17/2006)
  Jeffrey M. Taekman, MD and Melanie Clay Wright, Ph.D. from the Duke University Medical Center talk with GEN's Editor-in-Chief John Sterling about human simulation technology to improve clinical trial design.
• (8/10/2006)
  Joseph C. Kvedar, MD from Partners Telemedicine talks with GEN's Editor-in-Chief John Sterling about telemedicine applications in the biotechnology and pharmaceutical industries.
• (8/3/2006)
  Dr. Hui Lu and Ann Reed from BITmaP, an online bioinformatics training program, about careers in bioinformatics.
• (7/27/2006)
  Frank Slack, Ph.D. from Yale University talks with GEN's Editor-in-Chief John Sterling about microRNAs.
• (7/20/2006)
  Alan J. Russell, Ph.D., director of the McGowan Institute for Regenerative Medicine, talks with GEN's Editor-in-Chief John Sterling about tissue engineering.
• (7/13/2006)
  Dr. Christina Smolke from the California Institute of Technology talks with GEN's Editor-in-Chief John Sterling about the exciting new field of synthetic biology.
• (7/6/2006)
  Dr. George Church, Professor of Genetics at Harvard Medical School, talks with GEN's Editor-in-Chief John Sterling about The Personal Genome Project.
  sponsored by: Roche Applied Science
• (6/29/2006)
  Dr. Paul Richardson, from the U.S. Department of Energy's Joint Genome Institute, talks with GEN's Editor-in-Chief John Sterling about large-scale genome sequencing.
  sponsored by: Roche Applied Science
• (6/22/2006)
  Richard A. Gibbs, Ph.D., from the Baylor College of Medicine, talks with GEN's Editor-in-Chief John Sterling about frontiers in DNA sequencing.
  sponsored by: Roche Applied Science
• (6/15/2006)
  Dr. Stephan Schuster from Penn State University and Dr. William Farmerie from the University of Florida at Gainsville talk with GEN's Editor-in-Chief John Sterling about strategies for obtaining funding for novel bioresearch technologies.
  sponsored by: Roche Applied Science
• (6/8/2006)
  Lew Kontnik, Director of Brand Protection at Amgen, talks with GEN's Editor-in-Chief John Sterling about Counterfeit Pharmaceuticals.
• (6/1/2006)
  Dr. Una Ryan, from Avant Immunotherapeutics, talks with GEN's Editor-in-Chief John Sterling about recent developments in vaccine research.
• (5/25/2006)
  Dan Perry Executive Director of the Alliance for Aging Research, talks with GEN's Editor-in-Chief John Sterling about the societal implications of advances in biomedical research.
• (5/18/2006)
  Dr. Lee Lynd Associate Professor of Engineering at the Thayer School of Engineering at Dartmouth College, talks with GEN Editor-in-Chief John Sterling about bioethanol and biofuel.
• (5/11/2006)
  Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, talks with GEN Editor-in-Chief John Sterling about emerging infectious diseases around the globe.
• (5/4/2006)
  Dr. Raju Kucherlapati Scientific Director, Harvard-Partners Center for Genetics and Genomics & Paul Cabot Professor of Genetics, Harvard Medical School talks with GEN Editor-in-Chief John Sterling about personalized medicine and targeted approaches to diagnostics and therapy.
• (4/27/2006)
  Dr. Leroy Hood M.D. Co-founder of the Institute for Systems Biology in Seattle, Washington talks with GEN Editor-in-Chief John Sterling about Systems Biology.
• (4/20/2006)
  John Sterling talks with Bruce H. Littman, M.D., Vice President and Head, Global Translational Medicine, Pfizer Global Research and Development about translational medicine.
• (4/13/2006)
  ASSAY and Drug Development Technologies Editor-in-Chief James Inglese, Ph.D., Director - Biomolecular Screening and Profiling Division, NIH Chemical Genomics Center
• (4/6/2006)
  G. Steven Burrill, CEO of Burrill & Company.
• (3/30/2006)
  Brent Erickson from the Biotechnology Industry Organization discusses Industrial Biotechnology.
• (3/23/2006)
  Lynn D. Harper discusses commercial biotechnology opportunities in space.
• (3/16/2006)
  Rejuvenation Research Editor-in-Chief Aubrey de Grey Ph.D. talks about significantly increasing the human lifespan.

News

Articles

Blogs